thoracoscopically-assisted doxycycline sclerotherapy for a microcystic thoracoabdominal lymphatic malformation in a 3-month-old patient

Clicks: 114
ID: 182003
2016
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #59 of 72 articles by views in clinical medicine (london, england)

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Here we report successful thoracoscopic-assisted sclerotherapy of a large, prenatally diagnosed microcystic thoracoabdominal lymphatic malformation in a 3-month-old infant born at 38 weeks gestational age. Compression of the inferior vena cava and aortic displacement was demonstrated on imaging. Treatment options include medical management, percutaneous sclerotherapy, or surgical resection. The latter options were complicated by the location of this lesion. Therefore, sclerotherapy under direct visualization via thoracoscopy was performed with near resolution of the lesion after one treatment. This is the first description of treatment of a lymphatic malformation via this approach reported in the literature.
Reference Key
nissen2016journalthoracoscopically-assisted Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Alexander Nissen;A. Francois Trappey III;Mary Edwards
Journal clinical medicine (london, england)
Year 2016
DOI
10.1016/j.epsc.2015.12.004
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.